The impacts of anemia burden on clinical outcomes in patients with out-of-hospital cardiac arrest

Background: Out-of-hospital cardiac arrest (OHCA) has low survival rates, and few patients achieve a desirable neurological outcome. Anemia is common among OHCA patients and has been linked to worse outcomes, but its impact following the return of spontaneous circulation (ROSC) is unclear. This study examines the relationship between anemia burden and clinical outcomes in OHCA patients. Hypothesis: Higher anemia burden after ROSC may be related to higher mortality and worse neurologic outcomes. Methods: Patients who experienced OHCA and had ROSC were enrolled retrospectively. Anemia burden was defined as the area under curve from the target hemoglobin level over a 72-h period after OHCA. Hemoglobin level was measured at 12-h intervals. The clinical outcomes of the study included mortality and neurological outcomes at Day 30. Results: The study enrolled 258 nontraumatic OHCA patients who achieved ROSC between January 2017 and December 2021. Among the 162 patients who survived more than 72 h, a higher anemia burden, specifically target hemoglobin levels below 7 (hazard ratio [HR]: 1.129, 95% confidence interval [CI]: 1.013–1.259, p =.029), 8 (HR: 1.099, 95% CI: 1.014–1.191, p =.021), and 9 g/dL (HR: 1.066, 95% CI: 1.001–1.134, p =.046) was associated with higher 30-day mortality. Additionally, anemia burden with target hemoglobin levels below 7 (HR: 1.129, 95% CI: 1.016–1.248; p =.024) and 8 g/dL (HR: 1.088; 95% CI: 1.008–1.174, p =.031) was linked to worse neurological outcomes. Conclusions: Anemia burden predicts 30-day mortality and neurological outcomes in OHCA patients who survive more than 72 h. Maintaining higher hemoglobin levels within the first 72 h after ROSC may improve short-term outcomes.